NCT06803368View on ClinicalTrials.gov

Research on Clinical Recovery and Maintenance Strategies for CHB

NARecruitingINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 30, 2027

Study Completion Date

October 30, 2027

Conditions
Chronic Hepatitis bHepatitis B Vaccine
Interventions
BIOLOGICAL

baseline anti-HBs titer

Patients with baseline anti-HBs titer\<100 mIU/ml were randomly divided into two groups, group B and group C. Group B did not intervene, while group C received hepatitis B vaccine intervention and observed its indicators.

Trial Locations (1)

100015

RECRUITING

Beijing Ditan Hospital, Beijing

All Listed Sponsors
lead

Beijing Municipal Administration of Hospitals

OTHER_GOV